Kaneka Corporation has opened its Tomatoh Manufacturing Site in the Tomakomai Tobu Area of Hokkaido, Japan for the purpose of portfolio transformation and business expansion and recently held the opening ceremony. The Tomatoh Manufacturing Site is the seventh domestic business location for the company and the first new one in 54 years.

The medical device plant completed at Tomatoh Manufacturing Site will produce adsorption type blood purification devices Rheocarna and adsorption type plasma purification devices Liposorber.

The number of patients with arteriosclerosis obliterans (ASO), which these medical devices are intended to treat, is on the rise worldwide, along with increases in diabetes, chronic renal failure, and other conditions. By securing the supply base through the new plant, the company will dramatically expand its medical business to meet global demand.

The plant has achieved full automation of its production lines as a smart factory utilising robot technology and plans to realize a zero energy factory that will reduce the primary energy consumption of the factory building to zero by using our photovoltaic modules, thereby promoting sustainable manufacturing.

In the future, Tomatoh Manufacturing Site will be actively utilised as a new production base for each business, as well as for further expansion of the medical business.